drugset
drugset / Trial / NCT05219604

Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling

NCT05219604 ↗

Phase 4 Terminated 3 enrolled Dent Neuroscience Research Center
NaSingle-groupOpen-labelOther

Summary

This study seeks to explore the magnitude and duration of central nervous system effects and pharmacokinetics after intravenous infusion of diphenhydramine.

Timeline

Start
2022-03-15
Primary completion
2022-10-04
Completion
2022-10-04

Outcome

Outcome not reported

Stopped: “Institution decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphenhydramine Small molecule 50 mg Intravenous

Indications

No indication recorded.